Composition and structure elucidation of human milk glycosaminoglycans

Glycobiology

Volumn 21, Issue 3, 2011, Pages 295-303

  Coppa, Giovanni V ^a   Gabrielli, Orazio ^a   Buzzega, Dania ^a   Zampini, Lucia ^a   Galeazzi, Tiziana ^a   MacCari, Francesca ^b   Bertino, Enrico ^c   Volpi, Nicola ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

chondroitin sulfate; dermatan sulfate; glycosaminoglycans; heparin; human milk

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HEPARIN LYASE; HYALURONIC ACID; NITROUS ACID;

AGAR GEL ELECTROPHORESIS; ARTICLE; BREAST MILK; CARBOHYDRATE ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SULFATION;

ANIMALS; CATTLE; CHONDROITIN SULFATES; DERMATAN SULFATE; FEMALE; GLYCOSAMINOGLYCANS; HEPARIN; HEPARITIN SULFATE; HUMANS; MILK; MILK, HUMAN;

BOVINAE;

EID: 79551703799     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq164     Document Type: Article

References (29)

1. Achur RN, Valiyaveettil M, Gowda DC. 2003. The low sulfated chondroitin sulfate proteoglycans of human placenta have sulfate group-clustered domains that can efficiently bind Plasmodium falciparum-infected erythro-cytes. J Biol Chem. 278:11705
2. Carruthers VB, Håkansson S, Giddings OK, Sibley LD. 2000. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect Immun. 68:4005
3. Cesaretti M, Luppi E, Maccari F, Volpi N. 2003. A 96-well assay for uronic acid carbazole reaction. Carbohydr Polymers. 54:59
4. Conrad HE. 2001. Nitrous acid degradation of glycosaminoglycans. Curr Protoc Mol Biol. Chapter 17:Unit 17.22A
5. Coppa GV, Gabrielli O. 2008. Human milk oligosaccharides as prebiotics. In: Vresalovich J, Wilson M, editors. Therapeutic Microbiology: Probiotics and Related Strategies. Washington (DC): ASM Press, p. 131
6. Cunningham AS. 1979. Morbidity in breast-fed and artificially fed infants. II. J Pediatr. 95:685
7. Dainese L, Polvani G, Barili F, Maccari F, Guarino A, Alamanni F, Zanobini M, Biglioli P, Volpi N. 2007. Fine characterization of mitral valve glycosa-minoglycans and their modification with degenerative disease. Clin Chem Lab Med. 45:361
8. Deakin JA, Lyon M. 2008. A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sul-fates from biological samples. Glycobiology. 18(6):483
9. Frick IM, Schmidtchen A, Sjöbring U. 2003. Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells. Eur J Biochem. 270:2303
10. Hamosh M. 2001. Bioactive factors in human milk. Pediatr Clin North Am. 48:69
11. Hanson LA. 2007. Feeding and infant development breast-feeding and immune function. Proc Nutr Soc. 66:384
12. Jackson RJ, Busch SJ, Cardin AD. 1991. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 71:481
13. Kovar MG, Sedula MK, Marks JS, Fraser DW. 1984. Review of the epide-miologic evidence for an association between infant feeding and infant health. Pediatrics. 74:615
14. Mårdberg K, Trybala E, Tufaro F, Bergström T. 2002. Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells. J Gen Virol. 83:291
15. McClure MO, Moore JP, Blanc DF, Scotting P, Cook GM, Keynes RJ, Weber JN, Davies D, Weiss RA. 1992. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retroviruses. 8:19
16. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. 2005. Human milk glycans that inhibit pathogen binding protect breast-fed infants against infectious diarrhea. J Nutr. 135:1304
17. Newburg DS, Linhardt RJ, Ampofo SA, Yolken RH. 1995. Human milk gly-cosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor. J Nutr. 125:419
18. Newburg DS. 2009. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci. 87:26
19. Parveen N, Caimano M, Radolf JD, Leong JM. 2003. Adaptation of the Lyme disease spirochaete to the mammalian host environment results in enhanced glycosaminoglycan and host cell binding. Mol Microbiol. 47:1433
20. Raman R, Sasisekharan V, Sasisekharan R. 2005. Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol. 12:267
21. Rostand KS, Esko JD. 1997. Microbial adherence to and invasion through proteoglycans. Infect Immun. 65:1
22. Sasisekharan R, Raman R, Prabhakar V. 2006. Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng. 8:181
23. Shimizu M, Uryu N, Yamauchi K. 1981. Presence of heparin sulphate in the fat globule membrane of bovine and human milk. Agr Biol Chem. 45:741
24. Trowbridge JM, Gallo RL. 2002. Dermatan sulfate: New functions from an old glycosaminoglycan. Glycobiology. 12:117R
25. Volpi N. 1993. "Fast moving" and "slow moving" heparins, dermatan sulfate, and chondroitin sulfate: Qualitative and quantitative analysis by agarose-gel electrophoresis. Carbohydr Res. 247:263
26. Volpi N. 2009. High-performance liquid chromatography and on-line mass spectrometry detection for the analysis of chondroitin sulfates/hyalur-onan disaccharides derivatized with 2-aminoacridone. Anal Biochem. 388:140
27. Volpi N, Maccari F. 2002. Detection of submicrogram quantities of glycosa-minoglycans on agarose-gels by sequential staining with toluidine blue and Stains-All. Electrophoresis. 23:4060
28. Vongchan P, Warda M, Toyoda H, Toida T, Marks RM, Linhardt RJ. 2005. Structural characterization of human liver heparan sulfate. Biochim Biophys Acta. 1721:1
29. Wadstrom T, Ljungh L. 1999. Glycosaminoglycan-binding microbial proteins on tissue adhesion and invasion: Key events in microbial pathogenicity. J Med Microbiol. 48:223